This week marks the four year anniversary of RxTrace. The first essay, published on July 4, 2009, said it all, “Welcome to rxTrace“. And almost four years later I found myself yelling at the California Board of Pharmacy with my most recent essay, “Hey California Board of Pharmacy: Your Time Is Running Out!“. In between there have been 177 other essays of varying topics and varying quality. Thanks for sticking with me.
Readership has grown significantly over the last 1 1/2 years. I don’t make readership numbers public because they probably aren’t as big as one might imagine, but the growth has been incredible. RxTrace readers are people who are looking for information about pharma and medical device regulations and the technology solutions necessary to meet them. I call it, “a comprehensive exploration of the intersection between the pharmaceutical (and medical devices) supply chains, track & trace technology, standards and regulatory compliance”. That about sums it up, I think.
Here is a graph of the monthly pageviews for RxTrace since December 2010 (click on the image to enlarge).
Here is a list of the top ten essays written in the last year:
|1.||FDA Proposed UDI: A Revolution In Number Assignment||August 20th, 2012|
|2.||California Board of Pharmacy Clarifies Use Of GS1 EPCIS||December 17th, 2012|
|3.||E-Pedigree Vendor Selection||February 25th, 2013|
|4.||The New GS1 Healthcare US Track & Trace Guidance||March 11th, 2013|
|5.||InBrief: The Pharma Track & Trace Bill Has Passed the U.S. House Of Representatives||June 4th, 2013|
|6.||The Different Goals of Anti-Counterfeiting Technologies and Serialization||November 26th, 2012|
|7.||Could It Be The Cloud? More Thoughts On IBM’s Divestiture Of Its EPCIS And E-Pedigree Suite||October 8th, 2012|
|8.||The New Pharma Track & Trace Discussion Draft In The Senate||April 22nd, 2013|
|9.||Congressional Legislation Development: Mad Libs Edition!||October 29th, 2012|
|10.||California Responds To The Senate Pharma Track & Trace Discussion Draft||May 6th, 2013|
For a complete list of RxTrace essays sorted by their popularity over the last 12 months, see “Full List Of RxTrace Essays Ranked By Year 4 Clicks“. I’ve included the date they were published and the number of comments on each one. A nice resource.
THE FUTURE OF RxTRACE
I plan to continue writing RxTrace. In the coming year I hope to cover more topics in the areas of UDI, federal pedigree, FDA track & trace standards, GS1 Event-Based Traceability and other standards, pharma and medical devices serialization, California ePedigree, EU pharma track & trace, supply chain crimes, serialization regulations around the world, serialization technology, EPCIS, DPMS, Aggregation, Inference, Disaggregation, Decommissioning, 3PLs and other contract organizations, impact of serialization on chargebacks and other contract-related issues, and just maybe, RFID. I might even touch on the food and apparel supply chains as they compare with the pharma and medical devices supply chains. Who knows?
Thanks for reading. Stay tuned.